Chemoimmunotherapy Linked to HNSCC Response - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Chemoimmunotherapy Linked to HNSCC Response

Higher pathologic response rates with chemoimmunotherapy versus immunotherapy alone call for phase 3 trials, but survival implications remain unknown.

  • By

  • Andrea Surnit

  • June 5, 2026

  • 6 min

Share

Original Source(s)

Chemoimmunotherapy Linked to HNSCC Response

  • by Andrea Surnit

  • June 5, 2026

Related Content

Consensus Guidance May Improve Sinonasal Mass Outcomes

Multidisciplinary recommendations emphasize biopsy technique, imaging, and pathology review in patients with suspected sinonasal malignancy.

Ergonomic Risk in Head and Neck Surgery

Study suggests intraoperative pain and risk rise with case complexity and duration.

Symptom Scores May Signal Neuropathy Risk

Early recovery symptom patterns may help clinicians identify which oropharyngeal cancer survivors warrant closer neurologic surveillance.